THE WHAT? Pierre Fabre Laboratories has acquired a minority stake in French women’s wellness start-up, MiYé.
THE DETAILS The dermo-cosmetics brand aims to address hormonal imbalance, supporting women from puberty to menopause. Terms of the deal were not disclosed.
“Hormonal balance is a major stake that dermo-cosmetics shall address,” commented Frédéric Ennabli, CEO of Pierre Fabre Dermo-Cosmétique. “By partnering with MiYé, we are committed to providing our medical and dermatological expertise to develop the best possible responses to take care of all skins affected by hormonal variations.”
THE WHY? The investment is in line with Pierre Fabre Laboratories’ wider strategy to acquire stakes in fast-growing start-ups whose positioning complement its established dermo-cosmetics brands. Meanwhile, for MiYé, this first capital increase will help to ramp up development, carry out clinical studies, and build distribution in the pharmacy and drug store markets.